Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancerLisa Derosa, Bertrand Routy|Annals of Oncology|2018Cited by 863
Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancerLisa Derosa, Benjamin Besse, Fabio Cumbo et al.|Nature Medicine|2022Cited by 637
Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trialBertrand Routy, Saman Maleki Vareki, John Lenehan et al.|Nature Medicine|2023Cited by 446
A Natural Polyphenol Exerts Antitumor Activity and Circumvents Anti–PD-1 Resistance through Effects on the Gut MicrobiotaMeriem Messaoudene, Bertrand Routy, Reilly Pidgeon et al.|Cancer Discovery|2022Cited by 225
<i>Helicobacter pylori</i> infection has a detrimental impact on the efficacy of cancer immunotherapiesP Oster, Dominique Velin, Laurie Vaillant et al.|Gut|2021Cited by 169